Navigation Links
Zimmer Holdings to Present at 29th Annual Cowen and Co. Health Care Conference
Date:3/10/2009

WARSAW, Ind., March 10 /PRNewswire-FirstCall/ -- Zimmer Holdings, Inc. (NYSE: ZMH; SWX: ZMH) announced today it will be participating in the 29th Annual Cowen and Company Health Care Conference in Boston, Massachusetts, on March 17, 2009, at 8:45 a.m. Eastern Time.

A live webcast of the presentation can be accessed via Zimmer's Investor Relations website at http://investor.zimmer.com. The webcast will be archived for replay following the conference.

About the Company

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products. Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries. Zimmer's 2008 sales were approximately $4.1 billion. The Company is supported by the efforts of approximately 8,500 employees worldwide.

For more information about Zimmer, visit www.zimmer.com


'/>"/>
SOURCE Zimmer Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Third Quarter 2008 Results
2. Zimmer Holdings, Inc. Announces Agreement to Acquire Abbott Spine, an Innovator in Spinal Technology
3. Zimmer Holdings to Present at William Blair Growth Stock Conference
4. Zimmer Holdings to Present at Wachovia Healthcare Conference
5. Zimmer Holdings Announces Support for Elimination of Super-Majority Voting Requirements
6. Zimmer Announces Settlement of Federal Investigation
7. Zimmer and Tutogen Announce Agreement for International Distribution of Biological Products
8. Tutogen Medical, Inc. and Zimmer Holdings, Inc. Announce Agreement for International Distribution of Biological Products
9. China Pharma Holdings, Inc. Announces Clinical Trials Already Underway for Candesartan
10. China Pharma Holdings, Inc. Receives SFDA Production Approval for Tiopronin Enteric-Coated Capsules
11. InfuSystem Holdings Reports 14.5% Revenue Increase and Approximately $3.6 Million of Adjusted EBITDA for the Third Quarter of 2008

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...ntly announced that Dr. Dominique Hebrault will pr...nalytical Technology (PAT) in Green Chemistry and ... (PRWEB) November 20, 2009 -...ology (PAT) in Green Chemistry and Green Engineeri...nology (PAT) case studies will be presented on how...
(Date:11/19/2009)...e/ -- Dr. Mate Hidvegi, inventor of Avemar ferment... issued on November 17 by Biropharma Kft, discredi...lf-serving statements about its U.S. competitor Am... his office in Budapest, Hungary: ,, "The Biro...y to AveULTRA, www.aveultra.com , is misleading...
(Date:11/19/2009)...., Nov. 19 Arlington Medical Resou...ading driver of antibiotic selection in nosocomial...ainst gram-positive and gram-negative pathogens. D...comial pneumonia, surveyed European physicians rev...de appropriate coverage against common pathogens, ...
(Date:11/19/2009)...nthesis Companies Form International Gene Synthesi...n Risk Reduction ,Five Member Companies Represen... , (PRWEB) November 19, 20...esis companies today announced agreement that they... biosecurity in the gene synthesis industry. By s...
Breaking Biology Technology:Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4
...uly 1 BioMarin,Pharmaceutical Inc. (Nasdaq and SW...h.D., Chief Medical Officer of BioMarin, will pres... Conference in New York City on,Wednesday, July 9,...cess a live audio webcast of the presentation,via ...p://www.BMRN.com . A,replay of the presentation wi...
... Ben Eynon Each Assume Vice President Roles at ...N, Texas, July 1 Molecular Imprints, Inc., the,ma...ms and solutions, today,announced that Ben Eynon a...These distinguished industry veterans are assuming...ness development for semiconductors, and,vice pres...
...lized Psychiatric Patient Evaluation for Clinical ...ug Development, HAMILTON, N.J., July 1 MedAvante...ent evaluation, announced today that it has,closed...nd Trevi Health,Ventures. MedAvante has developed ... the assessment of patients undergoing treatment i...
Other Biology Technology:BioMarin to Present at the Collins Stewart Growth Conference 2Industry Veterans Join Molecular Imprints' Management Team 2Industry Veterans Join Molecular Imprints' Management Team 3MedAvante Closes $20 Million Financing by Goldman Sachs, Trevi Health Ventures 2MedAvante Closes $20 Million Financing by Goldman Sachs, Trevi Health Ventures 3MedAvante Closes $20 Million Financing by Goldman Sachs, Trevi Health Ventures 4
(Date:11/22/2009)...have succeeded in producing the polymers used for ...han through the use of fossil fuel based chemicals...w for the production of environmentally conscious ...l Biotechnology and Bioengineering to mark the j...ules found in everyday life in the form of plastic...
(Date:11/22/2009)...terfly,s proboscis looks like a straw -- long, sle...ke a paper towel, according to Konstantin Kornev o...s of this piece of insect anatomy to make small pr... Kornev will present his work next week at the 62...,s (APS) Division of Fluid Dynamics will take plac...
(Date:11/21/2009)...ewswire / - KINAXO Biotechnologies GmbH announce... new investors in the company, Leifina and Conmit ... Schumacher has been elected as a new member of th... Axel Ullrich, Hellmut Kirchner, Manfred Ferber as...tain Partners, BioM, High-Tech Grnderfonds, the Ma...
Breaking Biology News(10 mins):Bioengineers succeed in producing plastic without the use of fossil fuels 2KINAXO Completes Financing Round to Enhance Biomarker Development 2KINAXO Completes Financing Round to Enhance Biomarker Development 3WHO Withdraws Notice of Concern for Mylans Matrix Unit 13730 1NTU and Temasek Foundation transfer technology knowhow to Chinas quake prone regions 9723 1NTU and Temasek Foundation transfer technology knowhow to Chinas quake prone regions 9723 2NTU and Temasek Foundation transfer technology knowhow to Chinas quake prone regions 9723 3Kristi Yamaguchi Olympic Ice Skater Pushes Seasonal Flu Shots 55601 1Kristi Yamaguchi Olympic Ice Skater Pushes Seasonal Flu Shots 55601 2Kristi Yamaguchi Olympic Ice Skater Pushes Seasonal Flu Shots 55601 3
...DGE, Mass.-MIT scientists have found a way to indu...t could one day serve as tiny engineered blood ves...ol the cells, development by growing them on a sur...rk was posted this month in an online issue of Adv...d one day be transplanted into tissues such as the...
...ON, Ill. --- Neurotransmitters have consequences. ...y life, giving us the ability to move, to talk, to...ters are getting it right and sending proper signa...lls. , Now a Northwestern University study repor...controls a neurotransmitter in the nematode C. ele...
...ILLE, Tenn. U.S. Courts have decreed that the fe...naging nuclear wastes that will ensure the safety ...s, a period that is 200 times the length of record...rtainty in Long-Term Planning Nuclear Waste Manag...om government, industry, academia and the environm...
Other Biology News:MIT works toward engineered blood vessels 2Overexcited neurons not good for cell health 2Overexcited neurons not good for cell health 3Managing nuclear wastes for the millennia 2
VACUGENE PUMP 110V from GE Healthcare, formerly Amersham Biosciences
Rabbit Anti-DLK1 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Cryopreservation Service from AbD Serotec
...mismatch repair minus strains of E. coli. Use of t...zed unmethylated strand (1), leading to high mutat...ystems as the GeneEditor and Altered Sites II Muta...e recA+, therefore inserts containing highly repet...
Biology Products: